Five machine learning classifiers are benchmarked on a real, published GUIDE-seq off-target dataset and the low absolute precision achievable in this severely imbalanced, small-positive-class setting is reported, as a realistic picture of what off-target classifiers can and cannot yet deliver from sequence alone.
Abstract
Off-target cleavage is a central safety concern for CRISPR-Cas9 genome editing, particularly in therapeutic applications where unintended double-strand breaks carry clinical risk. We benchmarked five machine learning classifiers — logistic regression on mismatch-count summary features, a random forest and a gradient boosting model on one-hot-encoded sgRNA/candidate-site sequence pairs, a one-dimensional convolutional neural network (CNN) over the positional mismatch map, and a gradient-boosting/CNN ensemble — on a real, published GUIDE-seq off-target dataset (Kleinstiver et al., 2016, Nature) comprising 95,829 candidate off-target sites for five sgRNAs, of which only 54 (0.06%) were experimentally validated as true cleavage sites. On a held-out, stratified test split (n = 19,166; 11 true positives), gradient boosting on combined mismatch and sequence features performed best (ROC-AUC = 0.997, PR-AUC = 0.355, best F1 = 0.50), outperforming a random forest on raw sequence encoding alone (PR-AUC = 0.083) and a sequence CNN (PR-AUC = 0.129). Because the positive class is extremely rare, we report precision-recall AUC as the primary metric rather than ROC-AUC, which is inflated by the large negative class. A positional mismatch analysis showed that experimentally validated off-target sites carried substantially fewer mismatches overall than non-cleaved candidate sites (mean 3.6 vs. 5.9 mismatches across the 23-nucleotide target), and were markedly more mismatch-intolerant in the 10-nucleotide PAM-proximal seed region (11.3% vs. 27.4% per-position mismatch rate) and at the PAM itself (6.8% vs. 16.0%), consistent with established seed-region and PAM-sensitivity models of Cas9 target recognition. We report these findings, including the low absolute precision achievable in this severely imbalanced, small-positive-class setting, as a realistic picture of what off-target classifiers can and cannot yet deliver from sequence alone.
Abstract Summary CRISPR-Cas9 has become a widely used tool for genome editing. However, its off-target cleavage caused by partial sequence matches with guide RNAs (gRNAs) remains a critical limitation. Recently, abasic gRNAs (ØXØ) have been developed to enhance target specificity, but their effects vary depending on th...
Geun-Woo D. Kim, Dowoon Gu, Mingyo Park et al.· Bioinform.· 0 citations
Accurate identification of CRISPR-Cas9 off-target sites is essential for the safety assessment of genome-editing-based therapies. While numerous in silico prediction tools have been developed, their comparative performance and practical utility in preclinical workflows remain incompletely defined. We performed a system...
M. M. Kaufmann, Maren Hackenberg, William Jobson Pargeter et al.· Human Gene Therapy· 0 citations
It is very important to use uncertainty-aware models to improve the reliability of CRISPR predictions in this field, including predictive accuracy, confidence interval calibration and performance on out-of-distribution (OOD) data.
Track-seq2 provides a robust platform for sensitive off-target detection in primary cells, with sensitivity comparable to or exceeding current state-of-the-art methods.
This work systematically map over 200 split DNA activator configurations by introducing nicks at every position across both strands, revealing that target strand nicks suppress activity with position‐dependent severity, while non‐target strand nicks enhance activity.
Xiaoyan Tang, Zhe Li, Yu-Ning Lu et al.· Advancement of science· 0 citations
A crRNA-universal, sensitive and specific CRISPR-Cas12a detection platform, termed DESIC (double-end blocker and split-input mediated CRISPR-Cas12a system), for single-base mutation detection, targeting four prevalent pancreatic cancer KRAS mutations and optimized the system to achieve optimal discrimination.
Shi-Zhen Li, Yang-Wei Liao, Xiao-Xiang Wang et al.· Biosensors & bioelectronics· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.